[en] Obesity, particularly abdominal obesity, is the main risk factor for metabolic syndrome. However, some non-obese individuals are metabolically abnormal and therefore probably have an increased risk of cardiovascular disease. The present review paper aims to describe the main characteristics of the metabolically obese normal-weight (MONW) syndrome, analyse its etiopathogenesis and pathophysiology and, finally, assess its prevalence in various populations. [fr] L’obésité, notamment abdominale, est le facteur de risque principal du syndrome métabolique. Cependant, il existe manifestement des personnes non obèses qui sont métaboliquement anormales et, donc, vraisemblablement exposées à un risque accru de complications cardiovasculaires. Cet article vise à présenter les éléments conduisant au diagnostic du syndrome MONW (metabolically obese normal-weight), à tenter d’en cerner l’étiopathogénie et de mieux comprendre sa physiopathologie et, enfin, à analyser la prévalence de ce syndrome dans différentes populations.
Disciplines :
Endocrinology, metabolism & nutrition
Author, co-author :
Beck, Emmanuel ; Université de Liège - ULiège > Département des sciences cliniques > Département des sciences cliniques
Paquot, Nicolas ; Centre Hospitalier Universitaire de Liège - CHU > Diabétologie,nutrition, maladies métaboliques
Scheen, André ; Université de Liège - ULiège > Département des sciences cliniques > Diabétologie, nutrition et maladie métaboliques - Médecine interne générale
Language :
French
Title :
Sujets « métaboliquement obèses » de poids normal. Première partie: diagnostic, physiopathologie et prévalence
Alternative titles :
[en] Metabolically obese normal-weight subjects. Part One: diagnosis, pathophysiology and prevalence
Publication date :
2008
Journal title :
Obésité: Revue Francophone pour la Recherche Clinique, la Prévention et la Prise en Charge de l'Obésité
L.F. Van Gaal I.L. Mertens C.E. De Block 2006 Mechanisms linking obesity with cardiovascular disease Nature 444 875 880
J.P. Després I. Lemieux J. Bergeron 2008 Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk Arterioscler Thromb Vasc Biol 28 1039 1049
K.G.M.M. Alberti P. Zimmet J. Shaw for the IDF Epidemiology Task Force Consensus Group 2005 The metabolic syndrome - a new worldwide definition Lancet 366 1059 1062
S.M. Grundy J.I. Cleeman S.R. Daniels 2005 Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement Circulation 112 2735 2752
M.P. St-Onge I. Janssen S.B. Heymsfield 2004 Metabolic syndrome in normal-weight Americans: new definition of the metabolically obese, normal-weight individual Diabetes Care 24 2222 2228
N.B. Ruderman S.H. Schneider P. Berchtold 1981 The "metabolically- obese", normal-weight individual Am J Clin Nutr 34 1617 1621
N.B. Ruderman P. Berchtold S. Schneider 1982 Obesity-associated disorders in normal-weight individuals: some speculations Int J Obes 6 1 151 157
N. Ruderman D. Chisholm X. Pi-Sunyer S. Schneider 1998 The metabolically obese, normal-weight individual revisited Diabetes 47 699 713
Beck E, Scheen AJ (2008) Sujets « métaboliquement obèses » sans excès de poids: un phénotype interpellant. Rev Med Liège (sous presse)
F. Conus R. Rabasa-Lhoret F. Peronnet 2007 Characteristics of metabolically obese normal-weight (MONW) subjects Appl Physiol Nutr Metab 32 4 12
A.M. Prentice P. Rayco-Solon S.E. Moore 2005 Insights from the developing world: thirfty genotypes and thrifty phenotypes Proc Nutr Soc 64 153 161
R.V. Dvorak W.F. DeNino P.A. Ades E.T. Poehlman 1999 Phenotypic characteristics associated with insulin resistance in metabolically obese but normal-weight young women Diabetes 48 2210 2214
F. Conus D.B. Allison R. Rabasa-Lhoret 2004 Metabolic and behavioral characteristics of metabolically obese but normal-weight women J Clin Endocrinol Metab 89 5013 5020
Balkau B, Mhamdi L, Oppert JM, et al. (2008) Physical activity and insulin sensitivity. The RISC Study. Diabetes (Epub ahead of print)
Y.J. Hyun S.J. Koh J.S. Chae 2008 Atherogenecity of LDL and unfavorable adipokine profile in metabolically obese, normal-weight woman Obesity 16 784 789
Freedland ES (2004) Role of a critical visceral adipose tissue threshold (CVATT) in metabolic syndrome: implications for controlling dietary carbohydrates: a review. Nutr Metab (Lond) doi: 10.1186/1743-7075-1-12
A. Chiolero D. Faeh F. Paccaud J. Cornuz 2008 Consequences of smoking for body weight, body fat distribution, and insulin resistance Am J Clin Nutr 87 801 809
G.A. Colditz W.C. Willett A. Rotnitzky J.E. Manson 1995 Weight gain as a risk factor for clinical diabetes mellitus in women Ann Intern Med 122 481 486
T.A. Hillier A. Fagot-Campagna E. Eschwège 2006 Weight change and changes in the metabolic syndrome as the French population moves towards overweight: the DESIR cohort Int J Epidemiol 35 190 196
S. Klein D.B. Allison S.B. Heymsfield 2007 Waist circumference and cardiometabolic risk: a consensus statement from shaping America's health: Association for Weight Management and Obesity Prevention; NAASO, the Obesity Society; The American Society for Nutrition; and the American Diabetes Association Diabetes Care 30 1647 1652
M.C. Ryan H.M. Fernster Farin F. Abbasi G.M. Reaven 2008 Comparison of waist circumference versus body mass index in diagnosing metabolic syndrome and identifying apparently healthy subjects at increased risk of cardiovascular disease Am J Cardiol 102 40 46
J.M. Oppert M.A. Charles N. Thibult 2002 Anthropometric estimates of muscle and fat mass in relation to cardiac and cancer mortality in men: the Paris Prospective Study Am J Clin Nutr 75 1107 1113
A. De Lorenzo R. Martinoli F. Vaia L. Di Renzo 2006 Normal-weight obese (NWO) women: an evaluation of a candidate new syndrome Nutr Metab Cardiovasc Dis 16 513 523
L. Di Renzo V. Del Gobbo M. Bigioni 2006 Body composition analyses in normal-weight obese women Eur Rev Med Pharmacol Sci 10 191 196
C.S. Fox J.M. Massaro U. Hoffmann 2007 Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study Circulation 116 39 48
F.H. Luyckx A.J. Scheen P.J. Lefèbvre 2000 Non-alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss Diabetes Metab 26 98 106
H. Yki-Järvinen 2005 Fat in the liver and insulin resistance Ann Med 37 347 356
A. Katsuki Y. Sumida H. Urakawa 2003 Increased visceral fat and serum levels of triglyceride are associated with insulin resistance in Japanese metabolically obese, normal-weight subjects with normal glucose tolerance Diabetes Care 26 2341 2344
A.J. Scheen 2007 Évaluation de l'insulinosécrétion et de l'insulinosensibilité chez l'homme Thérapie 62 311 318
A. Katsuki H. Urakawa E.C. Gabazza 2005 Quantitative insulin sensitivity check index is a useful indicator of insulin resistance in Japanese metabolically obese, normal-weight subjects with normal glucose tolerance Endocr J 52 253 257
F.H. Luyckx A.J. Scheen 2003 L'hyperglycémie provoquée par voie orale: de la controverse à un plaidoyer pour sa place en biologie clinique Immuno-Anal Biol Spec 18 126 132
F. Abbasi J.W. Chu C. Malendola 2004 Discrimination between obesity and insulin resistance in the relationship with adiponectin Diabetes 53 585 590
A. Katsuki Y. Sumida H. Urakawa 2003 Plasma levels of adiponectin are associated with insulin resistance and serum levels of triglyceride in Japanese metabolically obese, normal-weight men with normal glucose tolerance Diabetes Care 26 2964 2965
A. Katsuki M. Suematsu E.C. Gabazza 2006 Decreased high-molecular weight adiponectin-to-total adiponectin ratio in sera is associated with insulin resistance in Japanese metabolically obese, normal-weight men with normal glucose tolerance Diabetes Care 29 2327 2328
E.S. Tai T.N. Lau S.C. Ho 2000 Body fat distribution and cardiovascular risk in normal-weight women. Associations with insulin resistance, lipids and plasma leptin Int J Obes Relat Metab Disord 24 751 757
A.D. Karelis D.H. St-Pierre F. Conus 2004 Metabolic and body composition factors in subgroups of obesity: what do we know? J Clin Endocrinol Metab 89 2569 2575
C. Moro S. Bajpeyi S.R. Smith 2008 Determinants of intramyocellular triglyceride turnover: implications for insulin sensitivity Am J Physiol Endocrinol Metab 294 203 213
L. Di Renzo M. Bigioni F.G. Bottini 2006 Normal-weight obese syndrome: role of single nucleotide polymorphism of IL-1 5Ralpha and MTHFR 677C->T genes in the relationship between body composition and resting metabolic rate Eur Rev Med Pharmacol Sci 10 235 245
M. Guerre-Millo 2008 Adiponectin: an update Diabetes Metab 34 12 18
E. Succurro M.A. Marini S. Frontoni 2008 Insulin secretion in metabolically obese, but normal-weight and in metabolically healthy but obese individuals Obesity 16 1881 1886
E. Ferrannini A. Natali P. Bell 1997 Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR) J Clin Invest 100 1166 1173
B.R. Walker R. Andrew 2006 Tissue production of cortisol by 11-beta-hydroxysteroid dehydrogenase type 1 and metabolic disease Ann NY Acad Sci 1083 165 184
R. Desbriere V. Vuaroqueaux V. Achard 2006 11-beta-hydroxysteroid dehydrogenase type 1 mRNA is increased in both visceral and subcutaneous adipose tissue of obese patients Obesity 14 794 798
J.M. Paterson N.M. Morton C. Fievet 2004 Metabolic syndrome without obesity: hepatic overexpression of 11-beta-hydroxysteroid dehydrogenase type 1 in transgenic mice Proc Natl Acad Sci USA 101 7088 7093
A. Katsuki M. Suematsu E.C. Gabazza 2006 Increased oxidative stress is associated with decreased circulating levels of adiponectin in Japanese metabolically obese, normal-weight men with normal glucose tolerance Diabetes Res Clin Pract 73 310 314
A. De Lorenzo V. Del Gobbo M.G. Premrov 2007 Normal-weight obese syndrome: early inflammation? Am J Clin Nutr 85 40 45
The DECODE Study Group 2008 Does the constellation of risk factors with and without abdominal adiposity associate with different cardiovascular mortality risk? Int J Obesity 32 757 762
T. McLaughlin G. Allison F. Abbasi 2004 Prevalence of insulin resistance and associated cardiovascular disease risk factors among normal-weight, overweight and obese individuals Metabolism 53 495 499
J.B. Meigs P.W.F. Wilson C.S. Fox 2006 Body mass index, metabolic syndrome and risk of type 2 diabetes or cardiovascular disease J Clin Endocrinol Metab 91 2906 2912
P.T. Katzmarzyk T.S. Church I. Janssen 2005 Metabolic syndrome, obesity and mortality. Impact of cardiorespiratory fitness Diabetes Care 28 391 397
E.S. Ford 2005 Prevalence of the metabolic syndrome defined by the International Diabetes Federation among Adults in the US Diabetes Care 28 2745 2749
Y.W. Park S. Zhu L. Palaniappan 2003 The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994 Arch Intern Med 163 427 436
I. Janssen P.T. Katzmarzyk R. Ross 2002 Body mass index, waist circumference, and health risk. Evidence in support of current National Institutes of Health guidelines Arch Intern Med 162 2074 2079
I. Janssen P.T. Katzmarzyk R. Ross 2004 Waist circumference and not body mass index explains obesity-related health risk Am J Clin Nutr 79 379 384
R.P. Widman P. Muntner K. Reynolds 2008 The obese without cardiometabolic risk factor clustering and the normal-weight with cardiometabolic risk factor clustering. Prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004) Arch Intern Med 168 1617 1624
B. Balkau P. Picard S. Vol 2007 Consequences of change in waist circumference on cardiometabolic risk factors over 9 years. Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR) Diabetes Care 30 1901 1903
B. Pannier F. Thomas E. Eschwège 2006 Cardiovascular risk markers associated with the metabolic syndrome in a large French population: the SYMFONIE study Diabetes Metab 32 467 474
S. Bo G. Ciccone N. Pearce 2007 Prevalence of undiagnosed metabolic syndrome in a population of adult asymptomatic subjects Diab Res Clin Pract 75 362 365
A.C. St-Pierre B. Cantin P. Mauriège 2005 Insulin resistance syndrome, body mass index and the risk of ischemic heart disease CMAJ 172 1301 1305
F. Hadaegh A. Zabetian H. Harati F. Azizi 2007 Metabolic syndrome in normal-weight Iranian adults Ann Saudi Med 27 18 24
P. Zimmet G. Alberti F. Kaufman 2007 The metabolic syndrome in children and adolescents Lancet 369 2059 2061
J.A. Morrison E.S. Ford J. Steinberger 2008 The pediatric metabolic syndrome Minerva Med 99 269 287
R. Kelishadi S.R. Cook M. Esmaeil 2008 Metabolically obese normal-weight and phenotypically obese metabolically normal youths: the CASPIAN study J Am Diet Assoc 108 82 90
V. Calcaterra C. Klersy T. Muratori 2008 Prevalence of metabolic syndrome (MS) in children and adolescents with varying degrees of obesity Clin Endocrinol (Oxf) 68 868 872
C. Maffeis C. Banzato G. Talamini 2008 Waist-to-height ratio, a useful index to identify high metabolic risk in overweight children J Pediatr 152 207 213
S.E. Messiah K.L. Arheart B. Luke 2008 Relationship between body mass index and metabolic syndrome risk factors among US 8-to 14-year-olds, 1999 to 2002 J Pediatr 153 215 221
S. Lee F. Bacha N. Gungor S. Arslanian 2008 Comparison of different definitions of pediatric metabolic syndrome: relation to abdominal adiposity, insulin resistance, adiponectin and inflammatory biomarkers J Pediatr 152 177 184
K.D. DuBose J.C. Eisenmann J.E. Donnelly 2007 Aerobic fitness attenuates the metabolic syndrome score in normal-weight, at-risk-for-overweight and overweight children Pediatrics 120 e1262 e1268
